DJIA 18,044.05 -82.07 -0.45%
NASDAQ 5,076.11 -21.86 -0.43%
S&P 500 2,111.90 -8.89 -0.42%
market minute promo

Isis Pharmaceuticals (NASDAQ: ISIS)

67.44 0.73 (1.09%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ISIS $67.44 1.09%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $66.67
Previous Close $66.71
Daily Range $66.51 - $68.45
52-Week Range $26.57 - $77.80
Market Cap $8.1B
P/E Ratio -333.55
Dividend (Yield) $0.00 (0.0%)
Volume 1,283,788
Average Daily Volume 2,262,475
Current FY EPS -$0.37

Sector

Healthcare

Industry

Drug Makers

Isis Pharmaceuticals (ISIS) Description

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases. Website: http://www.isispharm.com/

News & Commentary Rss Feed

The Best Business Model in Biotech

Understanding the three components that make up the best business model in biotech could make you a better investor and allow you to identify the sector's strongest stocks.

Can Isis Pharmaceuticals (ISIS) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tape

IWM, GDJJ: Big ETF Outflows

Alnylam's Cardiac Amyloidosis Drug Gets Orphan Status - Analyst Blog

IWM, VGLT: Big ETF Inflows

Why I'm Buying Sarepta Therapeutics Stock

Sarepta Therapeutics got some great news from the FDA yesterday that sent shares soaring. Here's why the stock is definitely worth a deeper dive by risk-tolerant investors.

Just What Is Invested Capital Anyway?

IWM, QRVO, ISIS, JBLU: ETF Inflow Alert

4 Biotech Stocks Could Have Big Upside Before Russell Index Changes

Akers Biosciences (AKER) Q1 Earnings: What's in Store? - Analyst Blog

See More ISIS News...

ISIS's Top Competitors

ISIS $67.44 (1.09%)
Current stock: ISIS
GILD $112.68 (-0.15%)
Current stock: GILD
CELG $114.88 (-0.04%)
Current stock: CELG
AMGN $156.78 (-0.36%)
Current stock: AMGN